Abbott

Abbott is engaged in pharmaceuticals and manufacturing healthcare products. It developed the first HIV blood-screening test. Its product portfolio includes Norvir, a treatment for HIV; Synthroid, a synthetic thyroid hormone; Depakote, an anticonvulsant drug; and Humira, a drug for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and more.

Abbott, established in 1944 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture investments across Health Care, Manufacturing, Medical Device, Financial Services, Venture Capital, Finance, Consumer, Enterprise Software, Biotechnology, Social Media. The organization boasts a portfolio of 10 investments, with an average round size of $20.8M and 4 successful exits. Their recent investments include Evalve, New Enterprise Associates, Split Rock Partners, Delphi Ventures, ABS Ventures. The highest investment round they participated in was $14.1B. Among their most notable exits are Evalve and New Enterprise Associates. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.